VITRASERT, INTRAVITREAL IMPLANT
VITRASERT, INTRAVITREAL IMPLANT
Discontinued
DIN Number
02233015
Drug Class
Human
Market Date
Mar 25, 1998
Company
HC
bausch & lomb inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02233015
AIG Number0128037003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
S01AD09 GANCICLOVIR
Product Specifications
Dosage FormImplant
Route of AdministrationIntravitreal
AHFS Classification08:18.32
Health Canada Classification
ACTIVE INGREDIENTS (1)
GANCICLOVIRActive
Strength: 4.5 MG / IMP
Monograph: GANCICLOVIR